ODI Logo ODI

Trending

Our Programmes

Search

Newsletter

Sign up to our newsletter.

Follow ODI

Debt relief evaluation: what is the impact of debt relief?

Date
Time (GMT +00) 13:00 14:00

Speakers:

Dr Geske Dijkstra, Associate Professor at Erasmus University, Rotterdam

Dr Romilly Greenhill, Economist, ActionAid
Chair:

Andrew Rogerson, ODI

Dr Geske Dijkstra introduced her presentation by outlining the design and methodology of her evaluation of Dutch debt relief for the Dutch IOB (Policy & Operations Evaluation Department). She then outlined the results of the evaluation in terms of stock, flow and conditionality, and she concluded with some remarks on the impact of the HIPIC initiative.

Dr Romily Greenhill responding said that had found herself in agreement with much of what Dr Dijkstra had said.

She thought that there was a need for an independent arbitration process around debt relief, and while Dr Dijkstra had been correlating debt relief with economic growth there was also a need to relate it to poverty reduction.

She would like to see a new process something like the US bankruptcy procedures for handling debt.

Description

This event discussed the results of an evaluation for the Policy and Operations Evaluation Department of the Netherlands' Ministry of Foreign Affairs.

Not many studies have been carried out on the effectiveness of debt relief. It is often assumed that debt relief will release resources for governments so that they can spend more on, for example, education and health. The results of this extensive study (eight country studies, a literature survey and an econometric study) show that the efficiency, effectiveness and relevance of international debt relief given during the 1990s - for achieving economic growth and poverty reduction - was limited. The amounts of debt relief were too small, debt relief was given in the wrong modalities and it was accompanied by too many new loans. In addition, the policy conditionality attached to debt relief was not effective and may even have had adverse effects. Although the enhanced HIPC initiative that began in 1999 implies some improvements, it leaves many important issues unresolved.